Akari Therapeutics plc ADR (0.01 USD)
N/A
USD
N/A
N/A
...
Chart
Financials
Description
AKTX Company Description
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).
AKTX Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view AKTX Smart Score
Score Breakdown
AKTX Company Description
Show More
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA). Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of AKTX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by AKTX's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on AKTX's company Twitter account
WallStreetBets
Number of mentions of AKTX in WallStreetBets Daily Discussion
AKTX News
Recent insights relating to AKTX
CNBC Recommendations
Recent picks made for AKTX stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in AKTX
Corporate Flights
Flights by private jets registered to AKTX
Our Analysis